Sandbox Reserved 975

This Sandbox is Reserved from 15/11/2014, through 15/05/2015 for use in the course "Biomolecule" taught by Bruno Kieffer at the Strasbourg University. This reservation includes Sandbox Reserved 951 through Sandbox Reserved 975.

To get started: Click the edit this page tab at the top. Save the page after each step, then edit it again. Click the 3D button (when editing, above the wikitext box) to insert Jmol. show the Scene authoring tools, create a molecular scene, and save it. Copy the green link into the page. Add a description of your scene. Use the buttons above the wikitext box for bold, italics, links, headlines, etc. More help: Help:Editing

ContextContext

The SUMO-conjugating enzyme UBC9 is involved in ubiquitination of proteins. The Ubiquitin is a small protein of 76 aa. Ubiquitination is a post translationnal modification where an ubiquitin is attached to a protein. This modification has several consequences, it can lead to the degradation of the protein via the proteasome, it can change the protein localization or it can alter the interaction of the protein with other factors, this is why this modification plays an important role in the control of many cellular processes. UBC9, in particular, is important in the cell cycle progression because it allows the degradation of S phase and M phase cyclines. Ubiquitination occurs in three steps : Activation performed by ubiquitin-activating enzymes E1, conjugation performed by ubiquitin-conjugating enzymes E2 and ligation performed by ubiquitin ligases E3. During the first step the Ct Carboxyl group of the ubiquitin is linked to the cystein sulfhydryl group of E1. The second step is a transesterification to transfer the active ubiquitin from the cystein of E1 to the cystein of E2. E2 binds the activated ubiquitin and E1. During the third step E3 catalyses the formation of an isopeptide bond between a lysine of the substrate and a glycine of the ubiquitin. UBC9 is a E2. It is a lynchpin in the SUMO pathway, it interacts with E1 during the activation, then with the ubiquitin after the transfer and finally with E3 during conjugation. It is particularly important for the formation of polymeric chain when the number of SUMO exceeds 2. Structure UBC9 is a monomer of 158 amino acids. It is comprised of a single domain with and , typical of the core domain of the UBCs. The dimensions of the surface are 20 Å X 30 Å X 50 Å. The core domain contains an antiparallel β-sheet with 4 strand (β1 to β4, residues 25-30, 36-46, 57-63, 74-77) And 4 αhelices (α1 to α4, residues 1-18, 109–121, 131-139, 141-154) This secondary structure represent 50% of the polypetide (33% α-helices and 17% β-sheets) There are two cis-prolines Pro69 and Pro79 that play an important role in the structure of the protein. Function The active site residue Cys 93 is located in a crevice formed by a loop between β4 and α2 (85-102) and another one between α2 and α3 (residues 122-130) 5 residues are the most likely to participate to the catalytic action because they are located within 6 Å of the sulfhydryl group of the accepting cysteine and that their side chains are oriented toward the Cysteine : Asn85, Tyr87, Glu98, Lys101, and Asp12 15 residues are well conserved among the UBC family : Gly47, Lys48, Gly56, Tyr68, Pro69, Pro73, Phe77, His83, Pro84, Asn85, Gly90, Trp103, Pro105, Leu120, and Pro12 Most of them are non polar and they are unlikely to have a direct role in the catalytic action but they are probably positionned to maintain the special configuration of the active site. Interaction with the substrates This is a sample scene created with SAT to by Group, and another to make of the protein. You can make your own scenes on SAT starting from scratch or loading and editing one of these sample scenes.

spinqualitylabelsall models Caption for this structure Show:Asymmetric Unit Biological Assembly Drag the structure with the mouse to rotate   Export Animated Image